Online ISSN 2313-1519
Print    ISSN 1812-2892
Abstract - The role of intestinal barrier function and the state of the intestinal microbiome in psoriasis
[PDF]           
Togzhan Algazina, Bakytgul Yermekbayeva, Almagul Kushugulova, Samat Kozhakhmetov, Zulfiya Jetpisbayeva, Gulnar Batpenova

ABSTRACT
The literature review summarizes the most recent and basic data on the state of the intestines and the features of the microbiome in psoriasis, as well as on the role of the immune system in this pathology. In patients with psoriasis, various microbial composition of the intestine was often identified, in particular, the main bacterial types of the genus Firmicutes, Bacteroidetes and Akkermansia.

Key words: intestinal microbiome, psoriasis, bacteria

 

Corresponding Author: Togzhan Algazina, Dermatovenereology Department, Astana Medical University. Address: 49A, Beibitshilik Street, Nur-Sultan city, Republic of Kazakhstan. Tel.: 87783441159. Е-mail:algazina.t@gmail.com

References

 

1. Nestle F.O., Kaplan D.H., Barker J. Psoriasis. Engl. J. Med. 2009; 361(5):496-509.
https://doi.org/10.1056/NEJMra0804595

2. Shakirov M.M., Taubaev A.A. Statisnicheskii eshegodnik «Indikatory dermatovenerologicheskoi pomoschi Respubliki Kazahstan. Almaty. 2016; 9

3. Davidovici B.B., Sattar N., Prinz J.C. Psoriasis and systemic infl ammatory diseases: potential mechanistic links between skin disease and co-morbid conditions. J. Invest. Dermatol. 2010; 130:1785-1796. https://doi.org/10.1038/jid.2010.103

4. Kriegel M.A., Self or non-self? The multifaceted role of the microbiota in immune-mediated diseases. ClinImmunol. 2015; 159(2):119-21. https://doi.org/10.1016/j.clim.2015.05.010

5. Gao Z., Tseng C.H, Strober B.E, et al. Substantial alterations of the cutaneous bacterial biota in psoriatic lesions. PLoS One. 2008; 23:3(7):e2719. https://doi.org/10.1371/journal.pone.0002719

6. Gomez A., Luckey D., Taneja V. The gut microbiome in autoimmunity: Sex matters. ClinImmunol. 2015;159(2):154-62. https://doi.org/10.1016/j.clim.2015.04.016

7. Arumugam M., Raes J., Pelletier E., et al. Enterotypes of the human gut microbiome. Nature. 2011; 473:174-80. https://doi.org/10.1038/nature09944

8. Koren O., Knights D., Gonzalez A., et al. A guide to enterotypes across the human body: meta-analysis of microbial community structures in human microbiome datasets. PLoSComput Biol. 2013; 9(1):e1002863. https://doi.org/10.1371/journal.pcbi.1002863

9. Duff L.C. Interaction mediating bacterial translocation in the immature intestine. J. Nutr. 2000; 130:432-436. https://doi.org/10.1093/jn/130.2.432S

10. Hardikov S.A., Nepomnyashcih G.I., Aidagulova S.V., Lapii G.A. Ul,trastrukturnaya harakteristika kletochnyx pohulyatsii slizistoi obolochki zheludka i dvenadtsatiperstnoi kishki pri psoriazhe. Byulleten, exsperimenl,noi biologii i meditsiny. 2002; 11:568-573

11. Shagova YU.V. Kliniko-pronostichoe znachenie funktsional,nyh i strukturnyh izmenenii kishechnika pri psoriaze: avtoref. diss. kand. med. nauk. Saratov. 2009; 22.

12. Tolmacheva N.V., Anisimov A.S. Sovremennyi vzglyad na etiologiyu i patogenez psoriaza. Fundamentalnye issledovaniya. 2015; 1(10):2118-2121.

13. Shagov Yu.V., Kozlova I.V. Kliniko-pronostichoe znachenie sostoyaniya slizistoi obolochki kishechnika pri psoriaze. Zdorov,e i obrazovanie XXI veke. 2007; 9 (4):22-24

14. Xardikova S.A., Beloborolova E.I., Pestetev P.N. Psoriaz, kishechnoe vsasyvanie. Tomsk, NTL, 2000; 120.

15. Stenina M.A., Kulagin V.I., Rudkovskaea Sh.V. i dr. Rol, narushenii bar,ernoi funktsii kishechnika v patogeneze psoriaza u detei. Ros.shurn. kosh. i ven.bol. 2003; 2:20-23.

16. Kulikova A.V., Zenin B.A., Uglova M.V.Morfologicheskie izmeneniya slizistoi tonkoi kishki pri psoriaze. Psoriaz: Respublikanskii sbornik nauchnyh rabot.1989; 18-21.

17. Shagov Yu.V. Kliniko-prognosticheskoe znachenie funktsional,nyh I strukturnyh izmenenii kishechnika pri psoriaze: aftoref.diss. kand.med.nauk. Saratov. 2009; 22.

18. Michaelsson G., Kraaz W., Hagforsen E. et al. Psoriasis patients have highly in-creased numbers of tryptase-positive mast cells in the duodenal stroma. Br. J. Der-matol. 1997; 36 (6):866-870. https://doi.org/10.1046/j.1365-2133.1996.d01-1088_136_6.x

19. Michaelsson G., Kraaz W., Hagforsen E. et al. The skin and the gut in psoriasis: the number of mast cells and CD3 lymphocytes is increased in non-involved skin and correlated to the number of intraepithelial lymphocytes and mast cells in the duode-num. Acta Dermato-Venereol. 1997; 77(5):343-346.

20. Pietzak A., Lecewicz-Torun B., Kadziela-Wypyska G. Changes in the digestive system in patients suffering from psoriasis. Ann. Univ. M. Curie-Sklodowska D. 1998; 53:187-194.

21. Chalmers R. J., Kirby B. Gluten and psoriasis. Br. J. Dermatol. 2000. 142(1):5-7.
https://doi.org/10.1046/j.1365-2133.2000.03345.x

22. Michaelsson G., Gerden B., Hagforsen E. et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br. J. Dermatol. 2000; 142(1):44-51.

https://doi.org/10.1046/j.1365-2133.2000.03240.x

23. Khardikova S.А., Beloborodova E.I. Sostoyanie pishevaritelnoi sistemy pri psoriaze. Clinicheskaya medicina. 2012; 2:13-15

24. Spiekermann G., Walker W.A. Oral tolerance and its role in clinical disease. J Pediatr Gastroenterol Nutr. 2001; 32:237-255. https://doi.org/10.1097/00005176-200103000-00003

25. Neish A.S. Microbes in gastrointestinal health and disease. Gastroenterology. 2009; 136:65-80. https://doi.org/10.1053/j.gastro.2008.10.080

26. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell. 2004; 118:229-241.
https://doi.org/10.1016/j.cell.2004.07.002

27. Sikora M., Chrabąszcz M., Maciejewski C. et al. Intestinal barrier integrity in patients with plaque psoriasis. J Dermatol. 2018; 45(12):1468-1470. https://doi.org/10.1111/1346-8138.14647

28. Richards D., Mein E., McMillin D., Nelson C. Systemic aspects of psoriasis: an integrative model based on intestinal etiology. Integrative Medicine. 2000; 2 (2):105-113(9).
https://doi.org/10.1016/S1096-2190(00)00010-X

29. Galland L. Power Healing: Use the New Integrated Medicine to Cure Yourself. Random House. 1998:384.

30. Raza K., Gerlag D.M. Preclinical inflammatory rheumatic diseases. Rheum Dis Clin North Am. 2014; 40(4):569-80. https://doi.org/10.1016/j.rdc.2014.07.001

31. Ruff W.E., Kriegel M.A. Autoimmune host-microbiota interactions at barrier sites and beyond. Trends Mol Med. 2015; 21(4):233-44. https://doi.org/10.1016/j.molmed.2015.02.006

32. Zanvit P., Konkel J.E., Jiao X. et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat Commun. 2015; 6:1-10. https://doi.org/10.1038/ncomms9424

33. Scher J.U., Ubeda C., Artacho A. et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015; 67:128-39. https://doi.org/10.1002/art.38892

34. Liberato M.V., Nascimento A.S., Ayers S.D. et al. Medium chain fatty acids are selective peroxisome proliferator activated receptor (PPAR) γ activators and Pan-PPAR partial agonists. PLoS One. 2012; 7:1-10. https://doi.org/10.1371/journal.pone.0036297

35. Masallat D., Moemen D.F., State A. Gut bacterial microbiota in psoriasis: A case control study. African J Microbiol Res. 2016; 10:1337-43.https://doi.org/10.5897/AJMR2016.8046

36. Codoñer F.M., Ramírez-Bosca A., Climent E. et al. Gut microbial composition in patients with psoriasis. Sci Rep. 2018; 8:1-7. https://doi.org/10.1038/s41598-018-22125-y

37. Atarashi K., Tanoue T., Shima T. et al. Induction of Colonic Regulatory T Cells. Science. 2011; 331:337-42. https://doi.org/10.1126/science.1198469

38. Qiu X., Zhang M., Yang X. et al. Faecalibacterium prausnitzii upregulates regulatory T cells and anti-inflammatory cytokines in treating TNBS-induced colitis. J Crohn's Colitis. 2013; 7:e558-68. https://doi.org/10.1016/j.crohns.2013.04.002

39. Khan M.T., Van Dijl J.M., Harmsen H.J.M. Antioxidants keep the potentially probiotic but highly oxygen-sensitive human gut bacterium Faecalibacterium prausnitzii alive at ambient air. PLoS One. 2014; 9:212-214. https://doi.org/10.1371/journal.pone.0096097

40.Quévrain E., Maubert M.A., Michon C. et al. Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut. 2016; 65:415-25.

41. Eppinga H., Sperna Weiland C.J., Thio H.B. et al. Similar depletion of protective Fae-calibacterium prausnitzii in psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa. J Crohn's Colitis. 2016; 10:1067-75. https://doi.org/10.1093/ecco-jcc/jjw070

 

Volume 2, Number 52 (2019)